Your browser doesn't support javascript.
loading
In vivo white matter microstructure in adolescents with early-onset psychosis: a multi-site mega-analysis.
Barth, Claudia; Kelly, Sinead; Nerland, Stener; Jahanshad, Neda; Alloza, Clara; Ambrogi, Sonia; Andreassen, Ole A; Andreou, Dimitrios; Arango, Celso; Baeza, Inmaculada; Banaj, Nerisa; Bearden, Carrie E; Berk, Michael; Bohman, Hannes; Castro-Fornieles, Josefina; Chye, Yann; Crespo-Facorro, Benedicto; de la Serna, Elena; Díaz-Caneja, Covadonga M; Gurholt, Tiril P; Hegarty, Catherine E; James, Anthony; Janssen, Joost; Johannessen, Cecilie; Jönsson, Erik G; Karlsgodt, Katherine H; Kochunov, Peter; Lois, Noemi G; Lundberg, Mathias; Myhre, Anne M; Pascual-Diaz, Saül; Piras, Fabrizio; Smelror, Runar E; Spalletta, Gianfranco; Stokkan, Therese S; Sugranyes, Gisela; Suo, Chao; Thomopoulos, Sophia I; Tordesillas-Gutiérrez, Diana; Vecchio, Daniela; Wedervang-Resell, Kirsten; Wortinger, Laura A; Thompson, Paul M; Agartz, Ingrid.
Afiliação
  • Barth C; Department of Psychiatric Research, Diakonhjemmet Hospital, Oslo, Norway. claudia.barth@medisin.uio.no.
  • Kelly S; Norwegian Centre for Mental Disorders Research (NORMENT), Institute of Clinical Medicine, University of Oslo, Oslo, Norway. claudia.barth@medisin.uio.no.
  • Nerland S; Department of Psychosis Studies, King's College London, London, UK.
  • Jahanshad N; Department of Psychiatric Research, Diakonhjemmet Hospital, Oslo, Norway.
  • Alloza C; Norwegian Centre for Mental Disorders Research (NORMENT), Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Ambrogi S; Imaging Genetics Center, Mark & Mary Stevens Neuroimaging & Informatics Institute, Keck School of Medicine, University of Southern California, Marina del Rey, CA, USA.
  • Andreassen OA; Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón, IiSGM, CIBERSAM, Madrid, Spain.
  • Andreou D; Laboratory of Neuropsychiatry, Santa Lucia Foundation IRCCS, Rome, Italy.
  • Arango C; Norwegian Centre for Mental Disorders Research (NORMENT), Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Baeza I; Norwegian Center for Mental Disorders Research (NORMENT), Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
  • Banaj N; Department of Psychiatric Research, Diakonhjemmet Hospital, Oslo, Norway.
  • Bearden CE; Norwegian Centre for Mental Disorders Research (NORMENT), Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Berk M; Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet & Stockholm Health Care Services, Stockholm Region, Stockholm, Sweden.
  • Bohman H; Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón, IiSGM, CIBERSAM, Madrid, Spain.
  • Castro-Fornieles J; School of Medicine, Universidad Complutense, Madrid, Spain.
  • Chye Y; Department Child and Adolescent Psychiatry and Psychology, 2017SGR881 Institute of Neuroscience, Hospital Clinic Barcelona. CIBERSAM. August Pi i Sunyer Biomedical Research Institute (IDIBAPS), University of Barcelona, Barcelona, Spain.
  • Crespo-Facorro B; Laboratory of Neuropsychiatry, Santa Lucia Foundation IRCCS, Rome, Italy.
  • de la Serna E; Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, UCLA, Los Angeles, CA, USA.
  • Díaz-Caneja CM; Department of Psychology, UCLA, Los Angeles, CA, USA.
  • Gurholt TP; Deakin University, Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Barwon Health, Geelong, Australia.
  • Hegarty CE; Department of Neuroscience, Child and Adolescent Psychiatry, Uppsala University, Uppsala, Sweden.
  • James A; Department of Clinical Science and Education Södersjukhuset, Karolinska Institutet, Stockholm, Sweden.
  • Janssen J; Department Child and Adolescent Psychiatry and Psychology, 2017SGR881 Institute of Neuroscience, Hospital Clinic Barcelona. CIBERSAM. August Pi i Sunyer Biomedical Research Institute (IDIBAPS), University of Barcelona, Barcelona, Spain.
  • Johannessen C; Turner Institute for Brain and Mental Health and School of Psychological Sciences, Monash University, Melbourne, VIC, Australia.
  • Jönsson EG; Hospital Universitario Virgen del Rocío, Universidad de Sevilla, Department of Psychiatry, CIBERSAM, IBiS-CSIC, Sevilla, Spain.
  • Karlsgodt KH; Department Child and Adolescent Psychiatry and Psychology, 2017SGR881 Institute of Neuroscience, Hospital Clinic Barcelona. CIBERSAM. August Pi i Sunyer Biomedical Research Institute (IDIBAPS), University of Barcelona, Barcelona, Spain.
  • Kochunov P; Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón, IiSGM, CIBERSAM, Madrid, Spain.
  • Lois NG; School of Medicine, Universidad Complutense, Madrid, Spain.
  • Lundberg M; Norwegian Centre for Mental Disorders Research (NORMENT), Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Myhre AM; Norwegian Center for Mental Disorders Research (NORMENT), Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
  • Pascual-Diaz S; Department of Psychology, UCLA, Los Angeles, CA, USA.
  • Piras F; Highfield Unit, Warneford Hospital, Oxford, UK.
  • Smelror RE; Department of Psychiatry, University of Oxford, Oxford, UK.
  • Spalletta G; Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón, IiSGM, CIBERSAM, Madrid, Spain.
  • Stokkan TS; Norwegian Centre for Mental Disorders Research (NORMENT), Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Sugranyes G; Norwegian Centre for Mental Disorders Research (NORMENT), Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Suo C; Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet & Stockholm Health Care Services, Stockholm Region, Stockholm, Sweden.
  • Thomopoulos SI; Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, UCLA, Los Angeles, CA, USA.
  • Tordesillas-Gutiérrez D; Department of Psychology, UCLA, Los Angeles, CA, USA.
  • Vecchio D; Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MA, USA.
  • Wedervang-Resell K; Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón, IiSGM, Madrid, Spain.
  • Wortinger LA; Department of Neuroscience, Child and Adolescent Psychiatry, Uppsala University, Uppsala, Sweden.
  • Thompson PM; Department of Clinical Science and Education Södersjukhuset, Karolinska Institutet, Stockholm, Sweden.
  • Agartz I; Section of Child and Adolescent Mental Health Research, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
Mol Psychiatry ; 28(3): 1159-1169, 2023 03.
Article em En | MEDLINE | ID: mdl-36510004
ABSTRACT
Emerging evidence suggests brain white matter alterations in adolescents with early-onset psychosis (EOP; age of onset <18 years). However, as neuroimaging methods vary and sample sizes are modest, results remain inconclusive. Using harmonized data processing protocols and a mega-analytic approach, we compared white matter microstructure in EOP and healthy controls using diffusion tensor imaging (DTI). Our sample included 321 adolescents with EOP (median age = 16.6 years, interquartile range (IQR) = 2.14, 46.4% females) and 265 adolescent healthy controls (median age = 16.2 years, IQR = 2.43, 57.7% females) pooled from nine sites. All sites extracted mean fractional anisotropy (FA), mean diffusivity (MD), radial diffusivity (RD), and axial diffusivity (AD) for 25 white matter regions of interest per participant. ComBat harmonization was performed for all DTI measures to adjust for scanner differences. Multiple linear regression models were fitted to investigate case-control differences and associations with clinical variables in regional DTI measures. We found widespread lower FA in EOP compared to healthy controls, with the largest effect sizes in the superior longitudinal fasciculus (Cohen's d = 0.37), posterior corona radiata (d = 0.32), and superior fronto-occipital fasciculus (d = 0.31). We also found widespread higher RD and more localized higher MD and AD. We detected significant effects of diagnostic subgroup, sex, and duration of illness, but not medication status. Using the largest EOP DTI sample to date, our findings suggest a profile of widespread white matter microstructure alterations in adolescents with EOP, most prominently in male individuals with early-onset schizophrenia and individuals with a shorter duration of illness.
Assuntos

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Transtornos Psicóticos / Esquizofrenia / Substância Branca Tipo de estudo: Guideline / Prognostic_studies Limite: Adolescent / Female / Humans / Male Idioma: En Revista: Mol Psychiatry Assunto da revista: BIOLOGIA MOLECULAR / PSIQUIATRIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Noruega

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Transtornos Psicóticos / Esquizofrenia / Substância Branca Tipo de estudo: Guideline / Prognostic_studies Limite: Adolescent / Female / Humans / Male Idioma: En Revista: Mol Psychiatry Assunto da revista: BIOLOGIA MOLECULAR / PSIQUIATRIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Noruega